Systematic Literature Review
& Network Meta-Analysis

Enabling Evidence-Based Decision Making

Before engaging with payers and reimbursement bodies, it is critical to have a full picture of the evidence supporting your product’s proposition. Evidence-based decision making is a key facet of the reimbursement and market access journey.

Market access and HEOR teams use the evidence generated through systematic literature reviews, network meta-analyses and other statistical methodologies to inform internal decisions about a product’s strategy.

A robust evidence base can help inform decisions around:

Critically, these evidence methodologies also form a key component of health technology assessment submissions, providing the evidence that enables reimbursement bodies to systematically evaluate whether a new treatment should be recommended for patient access.

Our experienced in-house team use the latest techniques and methods to develop research questions and protocols, as well as process and summarise the evidence found.

Choosing the right evidence generation methodology

Do you need a full systematic literature review, or would a rapid review address your requirements in a more timely and cost-effective way?

Would a network meta-analysis add to your evidence base?

How can statistical analyses support your market access and reimbursement goals?

The right approach will depend on your project goals. A systematic literature review is the gold standard for evidence generation and is required by most HTA bodies. However, if you are looking to build an evidence base to support internal decision-making and inform strategy, a rapid review may be an option to consider.

Our in-house systematic literature review analysts and data scientists draw on years of experience developing and reviewing evidence bases for both industry and HTA bodies, to recommend the best evidence methodologies to meet your needs.

To discuss your evidence requirements with our experts, get in touch using the form below.

    Choosing the right systematic literature review

    Here we explore the different options for literature reviews, including:

    • The gold-standard systematic literature review – It aims to identify all evidence relating to the research question to build a complete evidence base that avoids opinion and bias
    • Rapid or targeted review – An accelerated review that uses a streamlined methodology
    • Scoping review – A review that looks at the size of the evidence base rather than at the data within it
    • Review of reviews – Reviews the existing systematic literature reviews in the disease area of field of interest
    • Living review – A review that is updated regularly to incorporate new evidence
    Read more
    Which literature review is right for you?

    Choosing the right statistical analysis

    With a specialist statistician and information scientist in-house, we can further enhance your evidence base with meta-analyses, network meta-analyses and wider statistical analyses. We take a stepwise approach to ensure appropriate analyses are conducted that reflect your evidence base and project requirements.

    We can conduct both fixed- and random-effect meta-analysis as appropriate and explore heterogeneity, where feasible, using subgroup analyses or network meta-regression analyses to adjust for pre-specified covariates.

    We have experience with the following statistical methodologies:

    • Network Meta-Analysis
      • Bayesian analyses
      • Frequentist analyses
    • Bucher indirect treatment comparisons
    • Pair-wise meta-analysis

    Our evidence scientists are experts in

    • Evidence generation strategy
    • Systematic literature reviews – the gold standard for HTA and published evidence
    • Market landscape systematic literature reviews
    • Rapid reviews
    • Network meta-analysis
    • Critiques of previous systematic literature reviews and meta-analyses
    • Meta-analysis feasibility
    • Bespoke statistical analyses
    • Publication strategy

    Mtech Access is your go-to consultancy for Evidence Synthesis,
    Systematic Literature Reviews and Meta-analyses

    235
    projects
    30
    clients
    120
    publications
    • At Mtech Access, we have conducted 235+ evidence-synthesis-related projects with 30+ clients*. Of these projects, 60 involved a meta-analysis feasibility and/or subsequent meta-analysis
    • Our team have authored over 120 peer-reviewed journal articles and conference abstracts
    • We apply rigorous academic protocols to ensure all study questions are appropriately scoped and all relevant search sources examined
    • Systematic literature reviews and meta-analyses are conducted to conform to published guidelines
    • We have in-depth knowledge of global HTA body requirements, with the skills in-house to support your full submission or to supplement your teams’ capability where needed
    • In the UK, we have close relationships with over 80 contracted Associates working in the NHS, who work directly with us on projects as needed, to ensure the validity of our evidence generation

    *Includes any distinct project involving evidence synthesis for an external Pharmaceutical, Medtech, Biotech or Diagnostics client.

    • At Mtech Access, we have conducted 235+ evidence-synthesis-related projects with 30+ clients*. Of these projects, 60 involved a meta-analysis feasibility and/or subsequent meta-analysis
    • Our team have authored over 120 peer-reviewed journal articles and conference abstracts
    • We apply rigorous academic protocols to ensure all study questions are appropriately scoped and all relevant search sources examined
    • Systematic literature reviews and meta-analyses are conducted to conform to published guidelines
    • We have in-depth knowledge of global HTA body requirements, with the skills in-house to support your full submission or to supplement your teams’ capability where needed
    • In the UK, we have close relationships with over 80 contracted Associates working in the NHS, who work directly with us on projects as needed, to ensure the validity of our evidence generation

    *Includes any distinct project involving evidence synthesis for an external Pharmaceutical, Medtech, Biotech or Diagnostics client.

    Articles related to systematic literature reviews and meta-analysis

    Accelerating evidence synthesis in an infodemic

    Accelerating evidence synthesis in an infodemic

    On World Evidence-Based Healthcare Day (20th October 2021), Shona Lang (Senior Consultant -Evidence Synthesis), Stephanie Swift (Consultant – Evidence Synthesis) and Calum Jones (Consultant Health Economist) explore the role of…

    Selecting your evidence methodology - Which systematic literature review is right for you?

    Evidence Methodologies – Which systematic literature review is right for you?

    Finding, bringing together and synthesising a comprehensive evidence base is a key part of the reimbursement process and the wider market access journey for pharmaceutical products. This evidence generation process…

    Mtech Access webinar: Rare disease market access: Strategic and tactical challenges facing orphan medicines entering Europe - with Rob Taaffe (Associate Consultant, Global Market Access) Regina Leadley (Consultant, Systematic Review) and Calum Jones (Consultant, Health Economist)

    Rare disease market access live webinar: Strategic and tactical challenges facing orphan medicines entering Europe

    In this webinar, we explored the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are…